Increased Glomerular α1(IV) Collagen Expression and Deposition in Long-Term Diabetic Rats Is Prevented by Chronic Glycosaminoglycan Treatment

Laboratory Investigation

Volumn 74, Issue 2, 1996, Pages 484-495

  Ceol, Monica ^b   Nerlich, Andreas ^b   Baggio, Bruno ^b   Anglani, Franca ^b   Sauer, Ulrich ^b   Schleicher, Erwin ^b   Gambaro, Giovanni ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GLYCOSAMINOGLYCAN; HEPARIN DERIVATIVE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BASEMENT MEMBRANE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DIABETIC NEPHROPATHY; GENE EXPRESSION; GLOMERULUS BASEMENT MEMBRANE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; KIDNEY PROXIMAL TUBULE; MALE; MESANGIUM CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RAT;

ANIMALS; CHRONIC DISEASE; COLLAGEN; DIABETES MELLITUS, EXPERIMENTAL; DRUG ADMINISTRATION SCHEDULE; GLYCOSAMINOGLYCANS; HEPARIN; IN SITU HYBRIDIZATION; KIDNEY GLOMERULUS; MALE; RATS; RATS, SPRAGUE-DAWLEY; RNA, MESSENGER;

EID: 0030071528     PISSN: 00236837     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Abrass CK, Peterson CV, and Raugi GJ (1988). Phenotypic expression of collagen types in mesangial matrix of diabetic and nondiabetic rats. Diabetes 37:1695-1702.
2. Adler S (1988). Inhibition of rat glomerular visceral epithelial cell growth by heparin. Am J Physiol 255:F781-F786.
3. Ayo SH, Radnik R, Garoni JA, Troyer DA, and Kreisberg JI (1991a). High glucose increases diacylglycerol mass and activates protein kinase C in mesangial cell cultures. Am J Physiol 261:F571-F577.
4. Ayo SH, Radnik RA, Glass WF, Garoni JA, Rampt ER, Appling DR, and Kreisberg JI (1991b). Increased extracellular matrix synthesis and mRNA in mesangial cells grown in high-glucose medium. Am J Physiol 260:F185-F191.
5. Caenazzo C, Garbisa S, Ceol M, Baggio B, Borsatti A, Marchi E, and Gambaro G (1995). Heparin modulates proliferation and proteoglycan biosynthesis in murine mesangial cells: Molecular clues for its activity in nephropathy. Nephrol Dial Transplant 10:175-184.
6. Coffey AK and Karnovsky MJ (1985). Heparin inhibits mesangial cell proliferation in habu-venom-induced glomerular injury. Am J Pathol 120:248-255.
7. Danne T, Spiro MJ, and Spiro RG (1993). Effect of high glucose on type IV collagen production by cultured glomerular epithelial, endothelial, and mesangial cells. Diabetes 42:170-177.
8. Desjardins M, Gros F, Wieslander J, Gubler MC, and Bendayan M (1990). Immunogold studies of monomeric elements from the globular domain (NC1) of type IV collagen in renal basement membranes during experimental diabetes in the rat. Diabetologia 33:661-670.
9. Diamond JR and Karnovsky MJ (1986). Nonanticoagulant protective effect of heparin in chronic aminonucleoside nephrosis. Renal Physiol 9:366-374.
10. Falk RJ, Scheinman JI, Mauer SM, and Michael AF (1983). Polyantigenic expansion of basement membrane constituents in diabetic nephropathy. Diabetes 32(Suppl 2):34-39.
11. Floege J, Eng E, Young BA, Couser WG, and Johnson RJ (1993). Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis. Kidney Int 43:369-380.
12. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, and Koide H (1992). ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520-1527.
13. Gambaro G, Cavazzana AO, Luzi P, Piccoli A, Borsatti A, Crepaldi G, Marchi E, Venturini AP, and Baggio B (1992). Glycosaminoglycans prevent morphological renal alterations and albuminuria in diabetic rats. Kidney Int 42:285-291.
14. Gambaro G, Venturini AP, Noonan DM, Fries W, Re G, Garbisa S, Milanesi C, Pesarini A, Borsatti A, and Marchi E (1994). Treatment with a glycosaminoglycan formulation ameliorates experimental diabetic nephropathy. Kidney Int 46:797-806.
15. Hagege J, Delarue F, Peraldi MN, Sraer JD, and Rondeau E (1994). Heparin selectively inhibits synthesis of tissue type plasminogen activator and matrix deposition of plasminogen activator inhibitor 1 by human mesangial cells. Lab Invest 71:828-837,
16. Haneda M, Kikkawa R, Horide N, Togawa M, Koya D, Kajiwara N, Ooshima A, and Shigeta Y (1991). Glucose enhances type IV collagen production in cultured rat glomerular mesangial cells. Diabetologia 34:198-200.
17. Hasslacher C, Reichenbacher R, Gechter F, and Timpl R (1984). Glomerular basement synthesis and serum concentration of type IV collagen in streptozotocin-diabetic rats. Diabetologia 26:150-154.
18. Ichikawa L, Yoshida Y, Fogo A, Purkerson ML, and Klahr S (1988). Effect of heparin on the glomerular structure and function of remnant nephrons. Kidney Int 34:638-643.
19. Ihm CG, Lee GS, Nast CC, Artishevsky A, Guillermo R, Levin PS, Glassock RJ, and Adler SG (1992). Early increased renal procollagen alpha 1(IV) mRNA levels in streptozotocin induced diabetes. Kidney Int 41:768-777.
20. Kim Y, Butkowski R, Burke B, Kleppel MM, Crosson J, Katz A, and Michael AF (1991 a). Differential expression of basement membrane collagen in membranous nephropathy. Am J Pathol 139:1381-1388.
21. Kim Y, Kleppel MM, Butkowski R, Mauer SM, Wieslander J, and Michael AF (1991b). Differential expression of basement membrane collagen chains in diabetic nephropathy. Am J Pathol 138:413-420.
22. Kreisberg JI and Ayo SH (1993). The glomerular mesangium in diabetes mellitus. Kidney Int 43:109-113
23. Ledbetter S, Copeland EJ, Noonan D, Vogeli G, and Hassell JR (1990). Altered steady-state mRNA levels of basement membrane proteins in diabetic mouse kidneys and thromboxane synthase inhibition. Diabetes 39:196-203.
24. Mauer SM, Steffes MW, Ellis EN, Sutherland DE, Brown DM, and Goetz FC (1984). Structural-functional relationships in diabetic nephropathy. J Clin Invest 74:1143-1145.
25. Myrup B, Hansen PM, Jensen T, Kofoed Enevoldsen A, Feldt Rasmussen B, Gram J, Kluft C, Jespersen J, and Deckert T (1995). Effect of low-dose heparin on urinary albumin excretion in insulin-dependent diabetes mellitus. Lancet 1:421-422.
26. Nader HB, Buonassisi V, Colburn P, and Dietrich CP (1989). Heparin stimulates the synthesis and modifies the sulfation pattern of heparan sulfate proteoglycan from endothelial cells. J Cell Physiol 140:305-310.
27. Nerlich A and Schleicher E (1991). Immunohistochemical localization of extracellular matrix components in human diabetic glomerular lesions. Am J Pathol 139:889-899.
28. Nerlich AG, Schleicher ED, Wiest I, Specks U, and Timpel R (1994). Immunohistochemical localization of collagen VI in diabetic glomeruli. Kidney Int 45:1648-1656.
29. Olson JL (1984). Role of heparin as a protective agent following reduction of renal mass. Kidney Int 25:376-382.
30. Osterby R (1992). Glomerular structural changes in type 1 (insulin-dependent) diabetes mellitus: Causes, consequences, and prevention. Diabetologia 35:803-819.
31. Osterby R, Gall MA, Schmitz A, Nielsen FS, Nyberg G, and Parving HH (1993). Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 36:1064-1070.
32. Ottlinger ME, Pukac LA, and Kamovsky MJ (1993). Heparin inhibits mitogen-activated protein kinase activation in intact rat vascular smooth muscle cells. J Biol Chem 268:19173-19176.
33. Pukac LA, Ottlinger ME, and Karnovsky MJ (1992). Heparin suppresses specific second messenger pathways for protooncogene expression in rat vascular smooth muscle cells. J Biol Chem 267:3707-3711.
34. Purkerson ML, Joist JH, Greenberg JM, Kay D, Hoffsten PE, and Klahr S (1982). Inhibition by anticoagulant drugs of the progressive hypertension and uremia associated with renal infarction in rats. Thromb Res 26:227-240.
35. Purkerson ML, Tollefsen DM, and Klahr S (1988). N-desulfated/acetylated heparin ameliorates the progression of renal disease in rats with subtotal renal ablation. J Clin Invest 81:69-74.
36. Razzaque MS, Koji T, Taguchi T, Harada T, and Nakane PK (1994). In situ localization of type III and type IV collagen-expressing cells in human diabetic nephropathy. J Pathol 174:131-138.
37. Schleicher ED (1994). Biochemical aspects of diabetic nephropathy. In: Mogensen CE, editor. The kidney and hypertension in diabetes mellitus. Boston: Kluwer Academic Publishers, 191-202
38. Sharma K, Guo I, Jin Y, Eriksen M, and Ziyadeh FN (1994). Anti-TGF-B antibody attenuates renal hypertrophy and matrix expansion in diabetic mice (abstract). J Am Soc Nephrol 5:9727.
39. Steffes MW, Bilous RW, Sutherland DE, and Mauer SM (1992). Cell and matrix components of the glomerular mesangium in type I diabetes. Diabetes 41:679-684.
40. Tan EM, Dodge GR, Sorger T, Kovalszky I, Unger GA, Yang L, Levine EM, and Iozzo RV (1991). Modulation of extracellular matrix gene expression by heparin and endothelial cell growth factor in human smooth muscle cells. Lab Invest 64:474-482.
41. Wight TN (1989). Cell biology of arterial proteoglycans. Arteriosclerosis 9:1-20.
42. Wolf G, Sharma K, Chen Y, Ericksen M, and Ziyadeh FN (1992). High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-beta. Kidney Int 42:647-656.
43. Wright TC Jr, Pukac LA, Castellot JJ Jr, Karnovsky MJ, Levine RA, Kim Park HY, and Campisi J (1989): Heparin suppresses the induction of c-fos and c-myc mRNA in murine fibroblasts by selective inhibition of a protein kinase C-dependent pathway. Proc Natl Acad Sci USA 86:3199-3203.
44. Yamamoto T, Nakamura T, Noble NA, Ruoslahti E, and Border WA (1993). Expression of transforming growth factor beta is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818.
45. Ziyadeh FN (1993). The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22:736-744.
46. Ziyadeh FN, Sharma K, Ericksen M, and Wolf G (1994). Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforing growth factor-beta. J Clin Invest 93:536-542.